Tag: Cancer Treatment
-
Pancreatic Cancer: New Diagnostic Device Reframes Care
Introduction: A turning point in pancreatic cancer care Australia is witnessing a pivotal shift in the fight against one of its deadliest cancers. A new diagnostic device, designed to better identify tumor biology in pancreatic cancer, promises to tailor treatments more precisely than ever before. Health authorities, clinicians, and researchers are watching closely as this…
-
A New Diagnostic Device Is Changing How Australia Treats Pancreatic Cancer
A Breakthrough in Diagnosis Australia is witnessing a pivotal shift in the fight against one of its most lethal cancers. A new diagnostic device, developed by researchers and deployed in several Australian hospitals, promises to alter how pancreatic cancer is diagnosed and how treatment plans are formed. The approach centers on rapid, precise insights into…
-
KIRAN Inaugurates Second Halcyon LINAC in Karachi
KIRAN Expands Radiotherapy Capabilities with a Second Halcyon LINAC In a landmark move for cancer care in Pakistan, the Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN) has inaugurated its second Halcyon Linear Accelerator (LINAC). Operated by the Pakistan Atomic Energy Commission (PAEC), KIRAN is the country’s largest public-sector cancer hospital, renowned for delivering advanced…
-
KIRAN Hospital Expands Radiotherapy with Its Second Halcyon LINAC
Introduction: A milestone for public-sector cancer care Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), the country’s largest public-sector cancer hospital operated by the Pakistan Atomic Energy Commission (PAEC), has officially inaugurated its second Halcyon Linear Accelerator (LINAC). This expansion marks a significant step in widening access to cutting-edge radiotherapy for patients across Pakistan, reinforcing…
-
NHS expands access to Abiraterone in England to save thousands of lives
New policy expands access to Abiraterone across England The National Health Service (NHS) has broadened access to the prostate cancer drug Abiraterone across England. The move, announced by health authorities, aims to extend life-saving treatment to thousands of men diagnosed with prostate cancer at an early stage and to those whose disease has recurred. Abiraterone…
-
NHS Expands Access to Prostate Cancer Drug Abiraterone Across England to Save Thousands
England-wide expansion of Abiraterone offers new hope for prostate cancer patients The National Health Service (NHS) has announced a landmark expansion of access to Abiraterone, a medical treatment that blocks the hormones prostate cancer cells rely on to grow. Starting immediately, eligible men who are newly diagnosed with advanced stages of prostate cancer will be…
-
NHS Expands Access to Prostate Cancer Drug to Save Thousands of Lives in England
NHS Expands Access to Prostate Cancer Drug Across England The National Health Service (NHS) has broadened access to a revolutionary prostate cancer drug across England. Abiraterone, a medication that hinders cancer cells from obtaining the hormones they depend on to grow, will now be offered to men who are newly diagnosed with advanced prostate cancer…
-
New ‘Living Drug’ Brings Hope for Patients with Aggressive Blood Cancer on the NHS
Breakthrough therapy arrives on the NHS A new kind of treatment known as a “living drug” has begun to transform the outlook for patients with aggressive blood cancers. For the first time, an NHS patient has received this innovative therapy, sparking optimism within the medical community and among families affected by the disease. The treatment,…
-
Cu-Cy Nps@ZIF-8@HA-Mediated Photodynamic Therapy for Cutaneous Squamous Cell Carcinoma: A Promising Approach
Introduction to Cutaneous Squamous Cell Carcinoma and Photodynamic Therapy Cutaneous squamous cell carcinoma (CSCC) is one of the most common skin cancers, representing a significant portion of non-mmelanoma skin cancers worldwide. While many cases are treatable with surgery and radiation, novel therapies are needed for advanced or drug-resistant CSCC. Photodynamic therapy (PDT) has emerged as…
-
KAIST researchers wake sleeping immune cells to attack cancer
Groundbreaking approach to awaken the body’s own defenders Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have unveiled a novel method to turn a patient’s dormant immune cells into potent cancer fighters. The breakthrough suggests a simpler, potentially more accessible route to immunotherapy by reactivating immune responses that are often suppressed by…